Berry Global Group, a provider of design, development, and production of patient-centered healthcare solutions has inaugurated a new manufacturing facility and healthcare center in Bangalore. The product production at the facility will reportedly begin as early as April 2023. 

Leveraging the company’s innovative research and development (R&D) solutions, this new Greenfield expansion project aims to improve regional and global access to advanced healthcare solutions and provide customers with the necessary volume to support the forecasted growth for Asia’s domestic healthcare market.

Additionally, the new project will reportedly boost India’s domestic economy by employing more than 500 new team members over the next eight years in Bangalore.

“Healthcare companies have limited access to regional expertise and global capabilities needed to provide patient populations in Asia with modern healthcare solutions at scale,” said Tom Salmon, Berry Global's Chairman and chief executive officer (CEO). 

“Our new facility and global healthcare center of excellence in Bangalore will support Asia’s growing demand for healthcare products, create new jobs, and, most importantly, benefit the lives of patient populations who have historically gone untreated and underdiagnosed,” he added.

It is said that the new Bangalore plant will improve patients' access to products for the inhalation, nasal, ophthalmic, dispensing, and self-injection industries. While the new Berry Global Healthcare research and development center will support the development of innovative solutions for existing and new applications to improve medication administration and functionality.

The R&D center will be launching up to seven new products and projects in 2023 ranging from DPI inhalers to plastics caps and closures. Included among these products will be Berry’s Pneumohaler, a lightweight, breath-actuated, multidose inhaler dose counter for the control and treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD), said the company, adding that several new medical packaging products will be available for sampling with industrial prototypes in March 2023.

“Improved drug affordability and greater access to modern healthcare solutions are more important than ever in India, one of the most populated countries in the world. Our new facility and R&D center will benefit the domestic economy by creating new jobs and the regional economy overall by improving healthcare access and providing locally manufactured products,” said Jean-Marc Galvez, president of Consumer Packaging International.